Organization
Laboratoires Thea
7 clinical trials
Clinical trial
Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients.Status: Active (not recruiting), Estimated PCD: 2024-12-31
Clinical trial
Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous PatientsStatus: Completed, Estimated PCD: 2024-03-07
Clinical trial
Efficacy and Safety Assessment of T4090 Ophthalmic Solution (Preservative-free Kinezodianone R HCl 0.2% or 0.3%) Versus Rhopressa® Ophthalmic Solution (Preserved Netarsudil 0.02%) in Patients With Open-angle Glaucoma or Ocular HypertensionStatus: Not yet recruiting, Estimated PCD: 2025-05-01
Clinical trial
Systemic Pharmacokinetic Study of T4032 (Unpreserved Bimatoprost 0.01%) Eye Gel Versus Lumigan® 0.01% Eye Drops in 40 Healthy VolunteersStatus: Completed, Estimated PCD: 2023-04-05
Clinical trial
Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort® UD in Ocular Hypertensive or Glaucomatous Patients.Status: Completed, Estimated PCD: 2023-04-13
Clinical trial
Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous PatientsStatus: Completed, Estimated PCD: 2021-02-03